JDPNX | JVMSX | JDPNX / JVMSX | |
Total Expense Ratio | 0.65 | 1.25 | 52% |
Annual Report Gross Expense Ratio | 0.65 | 1.26 | 52% |
Fund Existence | 13 years | 13 years | - |
Gain YTD | -4.961 | -2.424 | 205% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.89B | 20.6B | 9% |
Annual Yield % from dividends | 0.98 | 0.46 | 215% |
Returns for 1 year | -7.15 | -8.45 | 85% |
Returns for 3 years | -3.40 | 4.66 | -73% |
Returns for 5 years | 20.96 | 50.94 | 41% |
Returns for 10 years | -19.18 | 27.80 | -69% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 78.04 | 0.69 | +0.89% |
SPDR® S&P Biotech ETF | |||
XBAP | 35.08 | 0.15 | +0.44% |
Innovator US Eq Acltd 9 Bfr ETFTM April | |||
MARW | 31.14 | 0.11 | +0.34% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
DFSI | 37.11 | -0.01 | -0.02% |
Dimensional International Sstby Cr 1 ETF | |||
BFIX | 25.14 | -0.08 | -0.30% |
Build Bond Innovation ETF |